These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32434801)

  • 1. Sequential interleukin 2 and pembrolizumab use in progressive multifocal leukoencephalopathy.
    Mahler C; Andrews M; Henson SM; Gnanapavan S
    Neurol Neuroimmunol Neuroinflamm; 2020 Jul; 7(4):. PubMed ID: 32434801
    [No Abstract]   [Full Text] [Related]  

  • 2. Single-Dose Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy.
    Beudel M; Rövekamp F; van de Beek D; Brouwer M
    Neurol Neuroimmunol Neuroinflamm; 2021 Jul; 8(4):. PubMed ID: 34039733
    [No Abstract]   [Full Text] [Related]  

  • 3. Pembrolizumab for progressive multifocal leukoencephalopathy due to primary immunodeficiency.
    Küpper C; Heinrich J; Kamm K; Bücklein V; Rothenfusser S; Straube A
    Neurol Neuroimmunol Neuroinflamm; 2019 Nov; 6(6):e628. PubMed ID: 31597693
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of Progressive Multifocal Leukoencephalopathy with Pembrolizumab.
    Rauer S; Marks R; Urbach H; Warnatz K; Nath A; Holland S; Weiller C; Grimbacher B
    N Engl J Med; 2019 Apr; 380(17):1676-1677. PubMed ID: 30969507
    [No Abstract]   [Full Text] [Related]  

  • 5. Ineffective treatment of PML with pembrolizumab: Exhausted memory T-cell subsets as a clue?
    Pawlitzki M; Schneider-Hohendorf T; Rolfes L; Meuth SG; Wiendl H; Schwab N; Grauer OM
    Neurol Neuroimmunol Neuroinflamm; 2019 Nov; 6(6):e627. PubMed ID: 31597692
    [No Abstract]   [Full Text] [Related]  

  • 6. Atypical MRI features at early onset natalizumab-associated progressive multifocal leukoencephalopathy: a case report.
    Piola M; Di Palma F; Mascoli N; Binda S; Arnaboldi M; Rezzonico M
    J Neurol Sci; 2014 May; 340(1-2):213-4. PubMed ID: 24642511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymptomatic progressive multifocal leukoencephalopathy associated with natalizumab.
    Mc Govern EM; Hennessy MJ
    J Neurol; 2013 Feb; 260(2):665-7. PubMed ID: 23212753
    [No Abstract]   [Full Text] [Related]  

  • 8. Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy.
    Cortese I; Muranski P; Enose-Akahata Y; Ha SK; Smith B; Monaco M; Ryschkewitsch C; Major EO; Ohayon J; Schindler MK; Beck E; Reoma LB; Jacobson S; Reich DS; Nath A
    N Engl J Med; 2019 Apr; 380(17):1597-1605. PubMed ID: 30969503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel treatments for progressive multifocal leukoencephalopathy.
    Bennett KM; Fernandes PM
    Br J Hosp Med (Lond); 2020 Jul; 81(7):1-9. PubMed ID: 32730143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pembrolizumab treatment for progressive multifocal leukoencephalopathy in a patient with Human Immunodeficiency Virus infection.
    Mozo Ruiz M; Rosado Barrasa N; Tena Gómez D; Torralba González de Suso M
    Enferm Infecc Microbiol Clin (Engl Ed); 2020 Oct; 38(8):396-397. PubMed ID: 32005559
    [No Abstract]   [Full Text] [Related]  

  • 11. Progressive multifocal leukoencephalopathy associated to natalizumab extended dosing regimen.
    Hervás JV; Presas-Rodríguez S; Crespo-Cuevas AM; Canento T; Lozano-Sánchez M; Massuet-Vilamajó A; Ramo-Tello C
    Neurodegener Dis Manag; 2015 Oct; 5(5):399-402. PubMed ID: 26517599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and magnetic resonance imaging monitoring in progressive multifocal leukoencephalopathy treated with pembrolizumab: a case report.
    Stögbauer J; Schulz-Schaeffer W; Mühl-Benninghaus R; Lochner P
    Neurol Sci; 2021 Jan; 42(1):357-359. PubMed ID: 32700225
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful treatment of HIV-associated progressive multifocal leukoencephalopathy with pembrolizumab.
    Sim BZ; Smith LK; Yarwood T; Smith S
    AIDS; 2022 Mar; 36(3):483-485. PubMed ID: 35084387
    [No Abstract]   [Full Text] [Related]  

  • 14. Monoclonal antibody therapy and progressive multifocal leukoencephalopathy.
    Jackson AC
    Can J Neurol Sci; 2011 Jul; 38(4):545-6. PubMed ID: 21672693
    [No Abstract]   [Full Text] [Related]  

  • 15. Sustained recovery of progressive multifocal leukoencephalopathy after treatment with IL-2.
    Kunschner L; Scott TF
    Neurology; 2005 Nov; 65(9):1510. PubMed ID: 16275856
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome with intravenous immunoglobulin in a patient with multiple sclerosis treated with fingolimod after discontinuation of natalizumab.
    Calic Z; Cappelen-Smith C; Hodgkinson SJ; McDougall A; Cuganesan R; Brew BJ
    J Clin Neurosci; 2015 Mar; 22(3):598-600. PubMed ID: 25523125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune checkpoint inhibitors for progressive multifocal leukoencephalopathy.
    Venniyoor A
    Saudi J Kidney Dis Transpl; 2019; 30(4):998-999. PubMed ID: 31464264
    [No Abstract]   [Full Text] [Related]  

  • 18. Brain Magnetic Susceptibility Changes in Patients with Natalizumab-Associated Progressive Multifocal Leukoencephalopathy.
    Hodel J; Outteryck O; Verclytte S; Deramecourt V; Lacour A; Pruvo JP; Vermersch P; Leclerc X
    AJNR Am J Neuroradiol; 2015 Dec; 36(12):2296-302. PubMed ID: 26316568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient punctuate enhancing lesions preceding natalizumab-associated progressive multifocal leukoencephalopathy.
    Taieb G; Renard D; Thouvenot E; Servillo G; Castelnovo G
    J Neurol Sci; 2014 Nov; 346(1-2):364-5. PubMed ID: 25241939
    [No Abstract]   [Full Text] [Related]  

  • 20. Progressive multifocal leucoencephalopathy in the era of natalizumab: a review and discussion of the implications.
    Greenlee JE
    Int MS J; 2006 Nov; 13(3):100-7. PubMed ID: 17101078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.